Baxter International Inc

BAX NYSE Healthcare & Biotech Monde US0718131099
20.03 $
4.11 %

Baxter International is a global leader in healthcare technology, providing products for dialysis, intensive care, nutrition, and fluid management.

Price history of Baxter International Inc
Price history of Baxter International Inc

Performance & Momentum

6 Months
1 Year
3 Years
5 Years 73.05 %

Strategic Analysis

Baxter International Inc • 2026

Baxter International occupies the position of an established medical technology player, with a model centered on devices, consumables, and care solutions for hospitals and patients. Its strength lies in a large installed base and recurring usage, which give it a defensive place within the healthcare ecosystem despite growth that has become more fragile.

Strengths
  • Global presence in products essential to hospitals and care pathways
  • Business supported by recurring usage and relatively defensive demand
  • Recognized brand in medical devices and hospital solutions
Weaknesses
  • Very poor stock momentum, indicating weakened market confidence
  • Weak long-term performance, reflecting operational or repositioning challenges
  • Exposure to a competitive sector where margin pressure can remain high
Momentum

Momentum appears weak and shows no clear sign of recovery, with a distinctly negative market trend across multiple time horizons. Strategically, this suggests a stock that is more suited to a wait-and-see approach than to a near-term recovery bet, in the absence of recent catalysts or any visible sign of an inflection point.

Similar stocks to Baxter International Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone